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Background: Diagnosis of amoebic liver abscess (ALA) in patients on anti-amoebic drugs is difficult. There is scanty
data on this issue using Entamoeba histolytica (E. histolytica) lectin antigen and polymerase chain reaction (PCR). We
studied utility of lectin antigen, PCR, and IgG antibody in diagnosis of liver abscess in patients on anti-amoebic
treatment. Liver aspirate of 200 patients, of which 170 had anti-amoebic drug prior to drainage, was tested for
E. histolytica lectin antigen by (ELISA), PCR, bacterial culture, and serum IgG antibody by (ELISA). Classification of
abscesses was based on result of anti-amoebic IgG antibody and bacterial culture, E. histolytica PCR and bacterial
culture, and E. histolytica lectin antigen and bacterial culture.
Findings: Using anti-amoebic IgG antibody and bacterial culture, 136/200 (68.0%) were classified as ALA, 12/200
(6.0%) as pyogenic liver abscess (PLA), 29/200 (14.5%) as mixed infection, and 23/200 (11.5%) remained unclassified.
Using amoebic PCR and bacterial culture 151/200 (75.5%) were classified as ALA, 25/200 (12.5%) as PLA, 16/200
(8.0%) as mixed infection, and 8/200 (4.0%) remained unclassified. With E. histolytica lectin antigen and bacterial
culture, 22/200 (11.0%) patients were classified as ALA, 39/200 (19.5%) as PLA, 2/200 (1.0%) as mixed infection, and
137/200 (68.5%) remained unclassified.
Conclusions: E. histolytica lectin antigen was not suitable for classification of ALA patients who had prior anti-
amoebic treatment. However, PCR may be used as alternative test to anti-amoebic antibody in diagnosis of ALA.
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Introduction
Amoebic liver abscess (ALA) is caused by protozoan
parasite Entamoeba histolytica (E. histolytica), a com-
mon parasitic infection in tropical countries [1-3]. Ap-
proximately 50 million people are infected with
E. histolytica annually world-wide, with mortality ran-
ging from 40,000 to 1,000,00 [4]. Most of the mortality
due to amoebiasis results from hepatic rather than intes-
tinal infection. Clinical and radiological features of ALA
are often somewhat similar with pyogenic liver abscess
(PLA). Hence, necessitating laboratory investigation for
differentiation between ALA and PLA are required [5].
Currently ALA is distinguished from PLA by microscopic* Correspondence: ghoshalujjala@yahoo.com
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reproduction in any medium, provided the orexamination, anti-amoebic IgG serology, and culture of
aspirate for pyogenic organisms.
Detection of trophozoites on microscopic examination
in liver aspirate, though confirmatory of ALA, is quite
insensitive [6,7]. Diagnosis of ALA is most frequently
made using serum anti-amoebic IgG antibody [8,9].
However, this assay may not distinguish past from
current infection, especially in endemic regions [10].
Thus, anti-amoebic IgG antibody may also be detected
in a proportion of healthy people [10,11].
Sensitivity and specificity of E. histolytica lectin anti-
gen have been reported to be as high as 80-90% in stool
and serum specimens for diagnosis of amoebiasis [12-
14]. Detection of E. histolytica lectin antigen in liver as-
pirate may also be useful for diagnosis of liver abscesses.
Unfortunately, scanty data available on lectin antigen de-
tection in liver aspirate are often contradictory [14,15].
Several PCR types like conventional, nested, touchdownLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tica DNA in stool samples and liver aspirate [7,12,16-
21]. Sensitivity and specificity of conventional PCR is
comparable with touchdown as well as real time PCR
[20,22]. Recently, amoebic DNA has been reported in
saliva and urine specimens with low sensitivity [23,24].
E. histolytica DNA detection in liver aspirate has been
found to be promising for diagnosis of ALA in a few re-
cent studies on a small number of patients [14,19,25,26].
Since the administration of antibiotics and anti-amoebic
drugs is common in developing countries like India
where amoebiasis is endemic, it is essential to evaluate
various diagnostic tests in these patients. Accordingly,
we aimed to evaluate the anti-amoebic IgG antibody test,
E. histolytica lectin antigen assay and conventional PCR
in association with bacterial culture for the diagnosis of
patients with liver abscess most of whom were on anti-
amoebic treatment.
Methods
We examined 220 patients who were subjected to drain-
age of liver abscesses in the radiology department of a
tertiary care center over a 3-yr-period (January 2006 to
December 2009). Among 200 patients with well-defined
liver abscess, 170 (85.0%) received an anti-amoebic drug
prior to drainage. Liver abscesses were diagnosed by ab-
dominal ultra-sonography. Patients not requiring aspir-
ation, or drainage, or finally diagnosed to have tubercular
or fungal abscesses were excluded from the study. Demo-
graphic and clinical parameters were recorded in a stand-
ard questionnaire. Informed consent was obtained from
all the patients and the protocol was approved by the
Institution’s (Sanjay Gandhi Postgraduate Institute of
Medical Sciences, Lucknow-India) Ethics Committee
(PGI/DIR/RC/957/2007).
Five ml of liver aspirate obtained during drainage of
abscesses were examined for bacteria using Gram stain-
ing and bacterial culture was also done using standard
media [27]. Sera obtained from these patients were
stored at -40 ° C till tested. Anti-amoebic IgG antibody
was assayed using a commercially available kit (Nova Tec
Immunodiagnostica GmbH, CITY, Germany) following
the manufacturer’s instructions. India is endemic for
amoebiasis. Accordingly, 100 age and sex matched volun-
teers were used as healthy controls for determination of
anti-amoebic IgG antibody titer in healthy population.
Based on optical density (OD) results from healthy
people, a cut-off OD value was determined using receiver
operating characteristic (ROC) curve. Serum with an ab-
sorbance in excess of cut-off OD on 450 nm was consid-
ered positive. E. histolytica lectin antigen in liver aspirate
was identified using commercially available kit (TechLab
E. histolytica II, Blacksburg, Virginia) within 24 hr or
stored at -40 ° C for no more than 7 days.DNA was isolated directly from the liver aspirate sam-
ples using CTAB (hexadecyltrimethylammonium brom-
ide) method [28]. A 125 base pair region of extra-
chromosomal circular DNA of E. histolytica was amplified
as previously described [19]. All PCR assays were repeated
twice for the validation of the result. DNA extracts from
E. histolytica strains HM-1:1MSS were used as positive
controls and E. dispar CDC 0784 as a negative control in
each PCR run.
Sensitivity, specificity, positive, and negative predictive
values (PPV, NPV) were calculated using standard for-
mulae [29]. Continuous and qualitative variables were
analyzed using independent sample t-test, Pearson’s Chi-
square, and Fisher’s exact test wherever appropriate.
Two-tailed P-values <0.05 were considered as significant.Results
Twenty patients were excluded from the final analysis as
a definite diagnosis could not be made due to inadequate
work-up (n = 12), or drainage not needed (n = 4), tuber-
cular liver abscesses (n = 2), and fungal liver abscesses
(n = 2). Demographic, clinical, imaging and laboratory
data of 200 patients with liver abscess are shown in Add-
itional file 1: Table S1. Patients with ALA were younger
in age, more often male, and had history of alcoholism,
diarrhea in the recent past, or blood in the stool (dysen-
teric). In contrast, patients with PLA were more often
diabetic, and had gall stones. On laboratory investigation,
patients with PLA had lower levels of serum albumin,
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), and higher hemoglobin than those with ALA. A
solitary lesion in right lobe of liver was seen more fre-
quently in ALA than PLA on imaging.
Bacteria were found in 41 of 200 (20.5%) liver aspirate
samples on microscopic examination of the Gram
stained smears and cultures. In 28 of 41 (68.3%) patients,
there was a single species of bacteria in their aspirate.
However, 13 of 41 (31.7%) patients had mixed infection
of bacteria in their aspirate. These included Escherichia
coli (n = 19), Klebsiella pneumoniae (n = 12), Pseudo-
monas aeruginosa (n = 6), Staphylococcus sp. (n = 4), Aci-
netobacter baumannii (n = 4), Enetrobacter sp. (n = 4),
Proteus vulgaris (n = 2), Morganella sp. (n = 1).
Based on the OD from healthy controls, a cut-off OD
value was designated. Best sensitivity (83%) and specifi-
city (63%) of a commercially available kit was calculated
using ROC curve at OD= 0.291. In total, 165 of 200
(82.5%) liver abscess patients produced an OD >0.291.
However, 35 of 200 (17.5%) patients with liver abscesses
had an OD< 0.291, while 141 of 170 (82.9%) patients
had anti-amoebic IgG antibody in their sera, which were
collected after initiation of the anti-amoebic drug. In
contrast, 24 of 30 (80.0%) patients had anti-amoebic IgG
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ation of the anti-amoebic drug (P=ns).
E. histolytica lectin antigen was present in 24/200
(12%) liver aspirate. Detection of lectin antigen in liver
aspirate was significantly lower in patients who had
received prior anti-amoebic treatment (4/170, 2.4% vs
20/30, 66.7%, P < 0.001).
Amoebic DNA was detected in 167/200 (83.5%)
patients. E. histolytica DNA was amplified more com-
monly in patients who had received prior anti-amoebic
drugs (144/170, 84.7% vs 23/30, 76.7%, P > 0.05).
Classification of liver abscesses using anti-amoebic IgG
antibody and bacterial culture
In 136 of 200 (68%) patients with liver abscess classified
as ALA as anti-amoebic IgG antibody was present in
their sera, and aspirate was sterile on bacterial culture.
Twelve of 200 (6.0%) patients were classified as pyogenic
as their sera did not show anti-amoebic IgG antibody,
while their aspirate culture revealed growth of a pyo-
genic organism. Twenty-nine of 200 (14.5%) were classi-
fied as mixed infection since their sera had anti-amoebic
IgG antibody and aspirate culture revealed presence of
bacteria; 23 of 200 (11.5%), however, remained unclassi-
fied as their sera did not have anti-amoebic IgG anti-
body and aspirate was also sterile on bacterial culture
(Table 1).
Classification of liver abscesses using E. histolytica PCR and
bacterial culture
In 151 of 200 (75.5%) patients with liver abscess were
classified as ALA as their aspirate had E. histolytica
DNA and bacterial culture was sterile. Twenty-five of
200 (12.5%) were classified as pyogenic, since their aspir-
ate did not show E. histolytica DNA but grew bacteria
on culture. Sixteen of 200 (8.0%) patients were classified
as having a mixed infection as their aspirate had both
E. histolytica DNA and bacteria grew on culture, while 8
of 200 (4.0%) remained unclassified as their aspirate did
not have E. histolytica DNA and bacterial culture was
sterile (Table 1).
Classification of liver abscesses using E. histolytica lectin
antigen and bacterial culture
Twenty-two of 200 (11.0%) patients with liver abscess
were classified as amoebic since their aspirate hadTable 1 Classification of patients with liver abscess using vari
PCR, E. histolytica lectin antigen and bacterial culture (n=200
Amoebic liver abscess
IgG Ab + Bacterial Culture 136, (68%)
Amoebic DNA + Bacterial Culture 151, (75.5%)
Lectin Antigen + Bacterial Culture 22, (11%)E. histolytica lectin antigen, but was sterile on bacterial
culture. Thirty-nine of 200 (19.5%) were classified as
pyogenic as their aspirate did not show E. histolytica lectin
antigen, but bacteria grew on culture, and 2 of 200 (1.0%)
were classified as mixed infections as their aspirate was
positive both for E. histolytica lectin antigen and bacterial
culture. However, 137 of 200 (68.5%) remained undiag-
nosed as their aspirate was negative for both E. histolytica
lectin antigen and bacterial culture (Table 1).
Using a combination of various tests, patients not clas-
sified into any category was highest by E. histolytica lec-
tin antigen and bacterial culture and lowest using
E. histolytica PCR and bacterial culture [8/200 (4.0%),
23/200 (11.5%), and 137/200 (68.5%) P= 0.000]. The
number of patients classified as ALA was highest using
E. histolytica PCR and bacterial culture, compared to
anti-amoebic IgG antibody and E. histolytica lectin with
bacterial culture [151/200 (75.5%), 136/200 (68.0%), and
22/200 (11%) P= 0.000] (Table 1).
Sensitivity and specificity
Patients with mixed and unclassified infections were
excluded for the calculation of sensitivity, specificity,
PPV, and NPV. Considering anti-amoebic IgG antibody
and bacterial culture as gold standards, sensitivity, speci-
ficity, PPV, and NPV of E. histolytica PCR and E. histoly-
tica lectin antigen ELISA were 99%, 91%, 99%, 91% and
15%, 100%, 100%, 9.3%, respectively. Using E. histolytica
PCR and bacterial culture as gold standard, sensitivity,
specificity, PPV, and NPV of anti-amoebic IgG antibody
and E. histolytica lectin antigen ELISA were 89%, 56%,
90%, 44% and 14.5%, 100%, 100%, 17%, respectively. The
measurement of agreement between anti-amoebic IgG
antibody and E. histolytica lectin antigen was low [kappa
value (k) = 0.002] and association between these 2 tests
were also not significant (P= 0.911). However, anti-
amoebic IgG antibody and E. histolytica PCR had agree-
ment (k = 0.456) and the 2 tests were significant
(P < 0.001, Table 2).
Discussion
The current study showed that E. histolytica lectin anti-
gen in association with bacterial culture of liver aspirate
was less useful in classifying liver abscesses. In contrast,
serum anti-amoebic IgG antibody or E. histolytica PCR
in combination with bacterial culture classified most ofous such as tests anti-amoebic IgG antibody, E. histolytica
)
Pygenic liver abscess Mixed Infection Unclassified
12, (6%) 29, (14.5%) 23, (11.5%)
25, (12.5%) 16, (8%) 8, (4%)
39, (19.5%) 2, (1%) 137, (68.5%)
Table 2 Agreement between anti-amoebic IgG antibody with E. histolytica-lectin antigen and E. histolytica-PCR among
ALA* and unclassified patients (n=159)




ALA 20 2 22 0.020 0.447
Unclassified 116 21 137
Total 136 23 159
Disease status ALA 135 15 150 0.456 0.001
by PCR Unclassified 1 8 9
Total 136 23 159
*Amoebic liver abscess
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cance of these conditions to a reasonable degree [3].
Our study showed that TechLab E. histolytica lectin
antigen test was not useful for diagnosis of ALA. This is
in contrast to 2 previously reported results in which
sensitivity of this test in liver aspirate sample were
40.7% and 50.0%, respectively [14,15]. Anti-amoebic
drugs are known to cause false negative results using
E. histolytica lectin antigen assay in an animal model
[30]. In a study published recently from Malaysia, 29 of
32 (90.6%) patients with ALA [31], E. histolytica lectin
antigen had become negative in sera within 48 hr of
metronidazole administration. Another study showed, 3
of 7 (42.9%) patients were positive for E. histolytica lec-
tin antigen prior to treatment while only 3/40 (7.5%)
patients had lectin antigen during or after treatment
[14]. The same study also reported that 9/11 (81.8%)
serum samples of patients with ALA had become nega-
tive for E. histolytica lectin antigen after 1 wk of anti-
amoebic treatment. In developing countries where
amoebiasis is endemic, anti-amoebic drugs are often
used indiscriminately. This could explain the low sensi-
tivity of E. histolytica lectin antigen test on liver aspirate
in our study. Thus, E. histolytica lectin antigen test is
not useful for diagnosis of ALA in patients receiving
anti-amoebic treatment.
One sample was negative by PCR but positive by IgG
antibody. The possible explanation to this could be pres-
ence of PCR inhibitors in liver aspirate as present in
stool samples. Although, we used inhibitors tablet to
optimize the PCR, some PCR inhibitors might be co-
extracted with the DNA, which inhibited the PCR.
One interesting finding of the present study is 2
patients with of ALA, which were diagnosed by PCR but
not by IgG antibody. Presence of amoebic DNA in two
liver aspirates specimens, establishes amoebic infection
in them. The negative result of ELISA (IgG) shows that
the host made an alternate mechanism for defense
against the parasite. The above cases present an interest-
ing area of research on defense mechanism in host
infected with E. histolytica.In the present study we have used conventional PCR
for diagnosis of ALA. Using E. histolytica PCR with bac-
terial culture, most of patients with liver abscess were
classified as ALA. E. histolytica PCR had greater sensi-
tivity for diagnosis of ALA than anti-amoebic IgG anti-
body. Twenty-three patients with liver abscess in the
present study could not be unclassified using anti-
amoebic antibody with bacterial culture. However, only
8 patients were remained unclassified by E. histolytica
PCR with bacterial culture. Thus in country like India
where real time PCR is not available in all laboratories,
conventional PCR can be used for the diagnosis of ALA.
It reduces cost of sample processing compared to in real
time and nested PCR.
Conclusions
E. histolytica lectin antigen in combination with bacterial
culture was least useful in classifying liver abscesses in
patients who had received anti-amoebic drug prior to
collection of the liver aspirate sample; in contrast, a
combination of serum anti-amoebic antibody or E. histo-
lytica PCR and bacterial culture classified most of the
liver abscesses successfully.
Additional file
Additional file 1: Table S1. Demographic and clinical features of 200
liver abscess patients classify using anti-amoebic IgG antibody and
bacterial culture.
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